These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM; Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties. Choueiri TK; Raghavan D Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983 [TBL] [Abstract][Full Text] [Related]
5. Current status of radiation therapy and combined-modality treatment for bladder cancer. Rödel C Strahlenther Onkol; 2004 Nov; 180(11):701-9. PubMed ID: 15549188 [TBL] [Abstract][Full Text] [Related]
6. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results. Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058 [TBL] [Abstract][Full Text] [Related]
7. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy. Shipley WU; Kaufman DS; Heney NM; Althausen AF; Zietman AL J Urol; 1999 Aug; 162(2):445-50; discussion 450-1. PubMed ID: 10411054 [TBL] [Abstract][Full Text] [Related]
8. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929 [TBL] [Abstract][Full Text] [Related]
9. Trimodality treatment and selective organ preservation for bladder cancer. Rödel C; Weiss C; Sauer R J Clin Oncol; 2006 Dec; 24(35):5536-44. PubMed ID: 17158539 [TBL] [Abstract][Full Text] [Related]
10. Radiotherapy and chemotherapy in invasive bladder cancer with potential bladder sparing. Kaufman DS; Shipley WU; Althausen AF Hematol Oncol Clin North Am; 1992 Feb; 6(1):179-94. PubMed ID: 1556049 [TBL] [Abstract][Full Text] [Related]
11. Selective bladder preservation by combination treatment of invasive bladder cancer. Kaufman DS; Shipley WU; Griffin PP; Heney NM; Althausen AF; Efird JT N Engl J Med; 1993 Nov; 329(19):1377-82. PubMed ID: 8413433 [TBL] [Abstract][Full Text] [Related]
12. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer. Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296 [TBL] [Abstract][Full Text] [Related]
14. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study. Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582 [TBL] [Abstract][Full Text] [Related]
15. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery. Merseburger AS; Kuczyk MA Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631 [TBL] [Abstract][Full Text] [Related]